Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075164
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075164
Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By Disease Indication, By End User, By Geography
PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Diagnostic Radioisotopes Market is estimated to be valued at USD 7.36 Bn in 2026 and is expected to reach USD 13.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.36 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.20% | 2033 Value Projection: | USD 13.63 Bn |
The global diagnostic radioisotopes market covers a broad set of radioisotope categories, including Technetium-99m, Thallium-201, and Gallium-67, used across applications such as Diagnostic Application and Therapeutic Application. Demand is supported by adoption among Hospitals, and Specialty Clinics and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.
Market Dynamics:
Growing adoption across Diagnostic Application and Therapeutic Application, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global diagnostic radioisotopes market. A wider range of available options is making these solutions accessible to a broader base of users.
For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Specialty Clinics. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global diagnostic radioisotopes market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Cardinal Health, Lantheus Holdings, Inc., Bayer AG, Bracco, Eckert & Ziegler, Nordion (Canada) Inc., NTP Radioisotopes, Curium, Jubilant Life Sciences Ltd, IRE, Isotopia Molecular Imaging Ltd., Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., Sumitomo Heavy Industries, Ltd., and Telix Pharmaceuticals Limited, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market.
Detailed Segmentation:
- Global Diagnostic Radioisotopes Market, By Radioisotope (Revenue, USD Bn, 2021 - 2033)
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- Others
- Global Diagnostic Radioisotopes Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Application and Therapeutic Application
- Global Diagnostic Radioisotopes Market, By Imaging Modality (Revenue, USD Bn, 2021 - 2033)
- SPECT
- PET
- Beta Emitters
- Global Diagnostic Radioisotopes Market, By Disease Indication (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Thyroid
- Orthopedic
- Endocrinology
- Others
- Global Diagnostic Radioisotopes Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Academic & Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- GE Healthcare*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Siemens Healthineers
- Koninklijke Philips N.V.
- Cardinal Health
- Lantheus Holdings, Inc.
- Bayer AG
- Bracco
- Eckert & Ziegler
- Nordion (Canada) Inc.
- NTP Radioisotopes
- Curium
- Jubilant Life Sciences Ltd
- IRE
- Isotopia Molecular Imaging Ltd.
- Mallinckrodt Nuclear Medicine LLC
- Jubilant DraxImage Inc.
- Sumitomo Heavy Industries, Ltd.
- Telix Pharmaceuticals Limited
"*" marked represents similar segmentation in other categories in the respective section.
Product Code: CMI6190
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Diagnostic Radioisotopes, By Radioisotope
- Market Diagnostic Radioisotopes, By Application
- Market Diagnostic Radioisotopes, By Imaging Modality
- Market Diagnostic Radioisotopes, By Indication
- Market Diagnostic Radioisotopes, By End User
- Market Diagnostic Radioisotopes, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
- Restraints
- High cost of diagnostic radioisotopes
- Opportunities
- Increasing adoption of hybrid imaging techniques
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Diagnostic Radioisotopes Market, By Radioisotope, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Thallium-201
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Gallium-67
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Iodine-123
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- FDG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Rubidium-82
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Diagnostic Radioisotopes Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- SPECT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- PET
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Beta Emitters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Diagnostic Radioisotopes Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Diagnostic Radioisotopes Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
9. Global Diagnostic Radioisotopes Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eckert & Ziegler
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nordion (Canada) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NTP Radioisotopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Curium
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jubilant Life Sciences Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IRE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Isotopia Molecular Imaging Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mallinckrodt Nuclear Medicine LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Jubilant DraxImage Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sumitomo Heavy Industries, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.